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ABSTRACT
Two alleles of segment 8 (NS) circulate in nonchiropteran influenza A viruses. The A allele is found in avian andmammalian
viruses, but the B allele is viewed as being almost exclusively found in avian viruses. This might reflect the fact that one or both of
its encoded proteins (NS1 and NEP) are maladapted for replication in mammalian hosts. To test this, a number of clade A and B
avian virus-derived NS segments were introduced into humanH1N1 and H3N2 viruses. In no case was the peak virus titer sub-
stantially reduced following infection of various mammalian cell types. Exemplar reassortant viruses also replicated to similar
titers in mice, althoughmice infected with viruses with the avian virus-derived segment 8s had reduced weight loss compared to
that achieved in mice infected with the A/Puerto Rico/8/1934 (H1N1) parent. In vitro, the viruses coped similarly with type I in-
terferons. Temporal proteomics analysis of cellular responses to infection showed that the avian virus-derived NS segments pro-
voked lower levels of expression of interferon-stimulated genes in cells than wild type-derived NS segments. Thus, neither the A
nor the B allele of avian virus-derived NS segments necessarily attenuates virus replication in a mammalian host, although the
alleles can attenuate disease. Phylogenetic analyses identified 32 independent incursions of an avian virus-derived A allele into
mammals, whereas 6 introductions of a B allele were identified. However, A-allele isolates from birds outnumbered B-allele iso-
lates, and the relative rates of Aves-to-Mammalia transmission were not significantly different. We conclude that while the intro-
duction of an avian virus segment 8 into mammals is a relatively rare event, the dogma of the B allele being especially restricted is
misleading, with implications in the assessment of the pandemic potential of avian influenza viruses.
IMPORTANCE
Influenza A virus (IAV) can adapt to poultry andmammalian species, inflicting a great socioeconomic burden on farming and
health care sectors. Host adaptation likely involves multiple viral factors. Here, we investigated the role of IAV segment 8. Seg-
ment 8 has evolved into two distinct clades: the A and B alleles. The B-allele genes have previously been suggested to be restricted
to avian virus species. We introduced a selection of avian virus A- and B-allele segment 8s into humanH1N1 and H3N2 virus
backgrounds and found that these reassortant viruses were fully competent in mammalian host systems.We also analyzed the
currently available public data on the segment 8 gene distribution and found surprisingly little evidence for specific avian host
restriction of the B-clade segment. We conclude that B-allele segment 8 genes are, in fact, capable of supporting infection in
mammals and that they should be considered during the assessment of the pandemic risk of zoonotic influenza A viruses.
Influenza A virus (IAV) belongs to the family Orthomyxoviridaeand has a negative-sense RNA genome consisting of 8 single-
stranded segments (1). IAV is subtyped according to its surface
glycoproteins hemagglutinin (HA) and neuraminidase (NA), of
which there are at least 16 and 9 different subtypes, respectively, in
nonchiropteran strains. The natural host of IAV is waterfowl, but
the virus is able to adapt to other avian andmammalian hosts. The
virus causes seasonal epidemics and sporadic pandemics in hu-
mans, as well as regular outbreaks in wild and domestic animals.
The determinants that facilitate the adaptation of an avian IAV to
a new host species are incompletely understood at present. Host
adaptation is likely influenced by a combination of multiple viral
and host factors. Of the viral factors, the HA protein (2, 3), re-
quired for virus entry into host cells, and the polymerase basic
protein 2 (PB2) (4), forming part of the trimeric RNA-dependent
RNA polymerase, are thought to play particularly important roles
in host adaptation, but most viral genes are likely to contribute
(reviewed in reference 5). There is currently a global fear that
avian influenza virus strains which are highly pathogenic in hu-
mans will adapt sufficiently to be able to spread readily within the
human population. Thus, it is of high importance to improve our
understanding of host adaptation and pathogenicity.
The nonstructural (NS) segment 8 of IAV encodes two major
polypeptides that are expressed in all strains: nonstructural pro-
tein 1 (NS1) and the nuclear export protein (NEP). NS1 is ex-
pressed following faithful transcription of the segment 8 viral
RNA (vRNA), while a pre-mRNA splicing event leads to NEP
expression (6). IAV replicates its genome in the host cell nucleus,
andNEP is essential for the nuclear export of viral ribonucleopro-
teins prior to virus egression (7). NEP has also been implicated in
other roles, such as regulating viral genome replication (8) and
assisting with virus budding (9). NS1 is amultifunctional, dimeric
crossmark
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protein, ranging in size from215 to 237 amino acids, that interacts
with RNA and a plethora of host cell proteins in a strain- and
host-specific manner to mediate its primary role of antagonizing
the host innate immune response (reviewed in reference 10). The
N-terminal 73 amino acids of NS1 constitute an RNA-binding
domain (RBD) that can bind a variety of both single- and double-
stranded RNAs with a low affinity (11, 12), and this is required to
inhibit the host antiviral RNase L pathway by preventing activa-
tion of 2=-5= oligoadenylate synthetase (OAS) (13). C terminal to
the RBD, connected by a short linker, is an effector domain (ED)
that forms interactions with many host cell factors. For example,
the NS1 protein of many strains binds and inhibits the host 30-
kDa cleavage and polyadenylation specificity factor (CPSF30) to
inhibit host cell mRNA processing, thus dampening the innate
immune response (14). The NS1 protein also binds host tripartite
motif-containing protein 25 (TRIM25) and prevents retinoic ac-
id-inducible gene I (RIG-I) ubiquitination following detection of
pathogen-associated molecular markers (PAMPs) and subse-
quent activation, thus inhibiting the induction of the type I inter-
feron (IFN) response (15). The products of the NS segment have
indeed been implicated in host adaptation and pathogenicity. For
instance, Li et al. concluded that the NS1 gene contributed to the
virulence of H5N1 avian influenza viruses (16), while adaptive
mutations in both the NS1 protein and NEP were found when
A/HongKong/1968 (H3N2)was adapted to increased virulence in
mice (17).
The NS segment of nonchiropteran IAV has classically been
divided into two alleles on the basis of nucleotide homology, the A
and B alleles (18), although recent findings from studies of H17
andH18 bat IAV isolates have initiated the use of the termC allele
(19–21). There is a striking divergence in the amino acid homol-
ogy of A- and B-allele NS1 proteins, where the identity between
the lineages can be as low as 63%but is typically above 93%within
an allele (22–24). The A- and B-allele groups encompass many
avian IAV isolates, but historically, all strains isolated frommam-
malian hosts, bar one H3N8 equine IAV isolate (25), belonged to
the A-allele group. Plausibly, this seeming bias reflects a host-
specific restriction, and consistent with this, there is long-standing
evidence that the B allele of the NS segment attenuates mammal-
adapted viruses. Treanor et al. generated segment 8 reassortant
viruses on the background of the human H3N2 A/Udorn/72
(Udorn72) virus and found that the B-allele reassortant gave sig-
nificantly reduced peak titers in the nasopharynx of squirrel mon-
keys in comparison to an A-allele counterpart and also had a
shorter duration of shedding (18). More recently, various B-allele
NS1 proteins from avian viruses were found to be less effective
than their A-allele counterparts at suppressing the activation of
the beta IFN (IFN-), NF-B, and AP-1 promoters in human and
mink lung cells (26–29). However, the introduction of a B-allele
NS segment from an H5N1 highly pathogenic avian influenza
(HPAI) virus into an HPAI H7N1 virus background increased
virus fitness inmammalian cells and allowed productive infection
of mice (30). Thus, there are conflicting data in the literature.
To better elucidate the role of the B-allele NS segment 8 in IAV
host adaption, we introduced a variety of avian influenza virus A-
and B-allele NS segments into human H1N1 viruses (laboratory-
adapted or 2009 pandemic [pdm2009] viruses) and H3N2 viruses
and assessed virus fitness in mammalian systems in vitro and in
vivo. We found no evidence for a B-allele-specific attenuation of
IAV replication or pathogenicity. We performed bioinformatic
and phylogenetic analyses on all influenza virus segment 8 se-
quences available in GenBank and estimated the nominal rates of
introduction of avian virus A- and B-allele NS segments into
mammalian hosts. We propose that these rates are comparable
and that the relative paucity of mammalian B-allele virus isolates
reflects their lower prevalence in the avian host, a theory that has
implications for the interpretation of surveillance data and assess-
ment of pandemic risk (31).
MATERIALS AND METHODS
Ethics statement. All animal experiments were carried out under the au-
thority of a UK Home Office Project License (60/4479) within the terms
and conditions of the strict regulations of the UK Home Office Animals
(Scientific Procedures) Act 1986 and the code of practice for the housing
and care of animals bred, supplied, or used for scientific purposes. Ethical
approval for experiments using human macrophages was obtained from
the Lothian Research Ethics Committee. All subjects provided written
informed consent at each donation.
Cell culture, viruses, plasmids, and antibodies.Madin-Darby canine
kidney (MDCK) cells, human embryonic kidney 293T cells (293T), and
human adenocarcinoma alveolar basal epithelial (A549) cells (Sigma Co.)
were grown in Dulbecco’s modified Eagle medium (D-MEM; Sigma Co.)
supplemented with 10% (vol/vol) fetal bovine serum (FBS), 2 mM glu-
tamine, 100 U/ml penicillin, and 100 g/ml streptomycin (complete D-
MEM). Madin-Darby canine kidney sialyltransferase 1 (MDCK-SIAT)
(32) cells were cultured as described above for MDCK cells with the ad-
dition of 1mg/mlGeneticin (GibcoCo.) to the culturemedium.HEK293-
Blue IFN-/ cells (HEK-Blue; InvivoGen) were cultured in complete
D-MEM supplemented with 30 g/ml blasticidin and 100 g/ml zeocin
(InvivoGen). Primary CD14 human monocytes were isolated from
whole blood as described previously (33). Monocytes were plated in 24-
well plates in RPMI supplemented with 10% (vol/vol) FBS, 2 mM glu-
tamine, 100 U/ml penicillin, 100 g/ml streptomycin (Sigma Co.), and
104 U/ml (100 ng/ml) recombinant human colony-stimulating factor 1
(rhCSF1; a gift from Chiron, Emeryville, CA, USA) for 7 days for differ-
entiation into macrophages. Infections were performed on day 8.
A/Puerto Rico/8/1934 (H1N1) (PR8) (34), A/California/7/2009 (H1N1)
(Cal7), andUdorn72 (H3N2) (35) viruses were generated by reverse genetics
essentially as described previously (36). Briefly, 106 human 293T cells were
transfected with plasmids carrying viruses generated by reverse genetics
(250 ng each), using 4 l of a cationic lipid mixture (Lipofectamine 2000
transfection reagent; Invitrogen, Life Technologies) according to the
manufacturer’s instructions. To generate NS segment reassortants, the
pDUAL plasmid for PR8 segment 8 was replaced with a pHH21 plasmid
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containing segment 8 from one of several low-pathogenic avian influenza
(LPAI) virus strains (Table 1). These plasmids were constructed with full-
length segment 8 cDNA generated by reverse transcription (RT)-PCR
using LPAI virus RNA (37) and primers (38) following standard protocols
(39). Additional pDUAL plasmids containing segment 8 cDNA from
other relevant virus strains (Table 1) were generated by synthesizing full-
length segment 8 genes (Biomatik) and cloning them into the pDUAL
vector using BsmBI restriction endonuclease sites (primer sequences are
available on request).Where full-length sequences, including the segment
untranslated regions, were not available, segment 8 termini from the clos-
est relativewere used (Table 1). AnyBsmBIDNA restriction endonuclease
sites within the segment 8 cDNA sequencewere synonymously changed to
remove the site without altering the NS1 protein or NEP sequence (Table
1). Cal7 (H1N1) gene segments were amplified by RT-PCR (primer se-
quences are available on request) and cloned into the pHW2000 vector
(40). On day 2, the medium was changed to serum-free D-MEM supple-
mented with 0.14% bovine serum albumin (wt/vol) and 5g/ml L-(tosyl-
amido-2-phenyl) ethyl chloromethyl ketone (TPCK)-treated trypsin
(Worthington Biochemicals) (RG medium). The supernatant was col-
lected on day 4, and virus was propagated either by using 0.1 ml of virus-
containing supernatant to infect T25 flasks of MDCK cells, maintained in
5 ml virus growth medium for 48 h, or by inoculating 2,000 PFU of virus
into the allantoic cavity of 10-day-old embryonated chicken eggs that
were maintained at 37°C for 72 h. Virus was titrated by standard plaque
assays on MDCK or MDCK-SIAT (for Cal7-based viruses) cells. The se-
quence of segment 8 of each virus was verified.
Polyclonal rabbit antisera to PR8 NS1 (antiserum V29), NEP (antise-
rum V13), nucleoprotein (NP; antiserum 2915), and matrix protein 1
(M1; antiserum2917) have been described previously (41–44). Polyclonal
rabbit antiserum against A/Mallard/Ohio/265/1987 (H1N9) (O265B)
NS1 residues 211 to 226 (antiserum A2) was raised by inoculating rabbits
with a keyhole limpet hemocyanin-peptide (CGPPLPPKQKRYMARRV)
conjugate. A mouse monoclonal antibody to influenza A virus matrix 2
ion channel protein (M2) was purchased from Abcam (catalog number
ab5416). Rat monoclonal antibody to -tubulin was purchased from Se-
rotec (clone YL1/2; catalog number MCA77G).
Viral protein expression analysis.MDCK cells in 24-well plates were
infected at amultiplicity of infection (MOI) of 3 for 8 h and lysed in 200l
SDS-PAGE loading buffer. Proteins were separated by SDS-PAGE and
transferred to nitrocellulose membranes for Western blotting. Mem-
branes were probed with primary antibody in phosphate-buffered saline–
0.1% (vol/vol) Tween 20. Themembranes were then probed with species-
specific anti-IgG secondary antibodies conjugated to infrared-fluorescent
dyes detectable using a LiCor Odyssey system. For radiolabeled immuno-
precipitation, cells were infected at anMOI of 10, and at 4 h postinfection
(p.i.), themediumwas changed toMet- and Cys-free D-MEM containing
5% (vol/vol) dialyzed bovine serum. At 6 h p.i., cells were pulsed with 0.4
MBq 35S protein labeling mix (PerkinElmer) in Met- and Cys-free D-
MEM. At 8 h p.i., the cells were lysed in a 0.1% SDS buffer (100 mMKCl,
50 mM Tris-HCl, pH 7.6, 5 mM MgCl2, 1 mM dithiothreitol, 1% Triton
X-100, 1% sodium deoxycholate). Clarified lysates were incubated with
rabbit polyclonal antiserum and protein A agarose (Roche). Immunopre-
cipitated proteins were eluted by boiling in SDS-PAGE sample buffer,
separated by SDS-PAGE, and detected using autoradiography. For radio-
labeling of whole-cell lysates, cells were infected at an MOI of 5 and ra-
diolabeled as described above at 8 h p.i. After 1 h, the cells were lysed and
the protein content was analyzed by SDS-PAGE and autoradiography.
Type I interferon assays. A549 cells were preconditioned with exoge-
nous human beta interferon (Abcam) for 24 h prior to a multicycle infec-
tion (MOI, 0.01). At 48 h p.i., cell lysates were generated for Western blot
analysis of viral NP and cellular interferon-induced GTP-binding protein
Mx-1 (Mx-1), and virus in the supernatant was titrated by plaque assay.
The 90% inhibitory concentration (IC90) values were calculated using
GraphPad Prism software (v6).
To assay IFN production, 180 l of an HEK-Blue cell suspension (at
2.8  105 cells/ml) was added to 20 l of a UV-treated (120,000 J/cm2
for 10 min; CL-1000 UV cross-linker; UVP) sample in 96-well plates and
incubated for 24 h at 37°C. Twenty microliters of the HEK-Blue cell su-
pernatant was transferred to 180l of Quanti-Blue substrate (InvivoGen)
in a separate 96-well plate and incubated for 1 h at 37°C. The absorbance
at 630 nm was recorded and used as a readout for active type I IFN levels
TABLE 1 Virus strains
Virus name Strain from which NS segment was isolated Allele GenBank accession no. (NS segment)
PR8 A/Puerto Rico/8/1934 (H1N1) A EF467817.1
Cal7 A/California/7/2009 (H1N1) A Unpublished
Udorn72 A/Udorn/72 (H3N2) A CY009640.1
O175Aa A/green-winged teal/Ohio/175/1986 (H2N1) A CY018881.1
O173A A/mallard/Ohio/173/1990 (H11N9) A CY021665.1
O340A A/green-winged teal/Ohio/340/1987 (H11N9) A CY021873.1
M1124A A/mallard/Maryland/1124/2005 (H11N9) A CY021473.1
O265Ba A/Mallard/Ohio/265/1987 (H1N9) B CY017279.1
O430B A/green-winged teal/Ohio/430/1987 (H1N1) B CY011044.1
O264B A/mallard/Ohio/264/1986 (H3N8) B CY016399.1
O339B A/pintail/Ohio/339/1987 (H3N8) B CY019201.1
O668B A/mallard/Ohio/668/2002 (H4N6) B CY020793.1
O671B A/mallard/Ohio/671/2002 (H4N6) B CY020801.1
O35B A/northern shoveler/Ohio/35/1986 (H3N8) B CY020937.1
O246B A/bufflehead/Ohio/246/1986 (H11N2) B CY017079.1
Alb88Bb A/mallard/Alberta/88/1976 (H6N8) B M25373.1
NY6750Ac A/mallard/New York/6750/1978 (H2N2) A M25376.1
Sw418Bd A/mallard/Sweden/S90418/2005 (H6N8) B EU518722
NY107Be A/New York/107/2003 (H7N8) B EU587374.2
J89B A/equine/Jilin/1/1989 (H3N8) B M65020.1
a Used as representative consensus A- and B-allele genes for specific experiments.
b Residues 1 to 15 and 855 to 890 from ALB/221/1978 (H7N2) (GenBank accession no. CY005035.1). The G242A mutation was introduced to remove the BsmBI site.
c Residues 1 to 16 and 855 to 890 from A/mallard/New York/6750/1978 (H2N2) (GenBank accession no. M80945.1).
d Residues 1 to 26 and 882 to 890 from A/tufted duck/Mongolia/1409/2010 (H1N1) (GenBank accession no. KC871435.1). The A696C mutation was introduced to remove the
BsmBI site.
e Residues 1 to 15 and 871 to 890 from A/guinea fowl/New York/20221-11/1995 (H2N2) (GenBank accession no. CY014833.1).
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in the initial samples. A standard curve was generated in parallel using
known quantities of human IFN-.
Human and mouse cytokine protein arrays. Human blood mono-
cyte-derivedmacrophages (MDMs) were infected at anMOI of 1 for 24 h.
Cytokine profiling of clarified supernatantswas performedusing a human
cytokine array kit (human cytokine array kit, panel A; R&D Systems) and
the near-infrared fluorescence detection protocol as instructed by manu-
facturer. Lung homogenates from BALB/c mice culled at day 4 p.i. were
pooled and clarified, and cytokine profiling was performed using amouse
cytokine array kit (mouse cytokine array kit, panel A; R&D Systems) as
described above.
Quantitative proteomics. Human lung A549 cells (1  107) in
100-mm by 20-mm dishes were infected at an MOI of 5 for either 8 h, 16
h, or 24 h. Cells were lysed in a 6M guanidine lysis buffer, and lysates were
sonicated using a water bath sonicator. Lysates were clarified by centrifu-
gation at 21,000 g for 10min andwere frozen in liquid nitrogen. Lysates
were then processed for mass spectrometry as previously described (45).
Briefly, protein was digested with LysC and then trypsin. Peptides were
labeled with tandem mass tag (TMT) reagents, and 12 fractions were
generated by high-pH reversed-phase high-performance liquid chroma-
tography. Mass spectrometry was performed using an Orbitrap Fusion
mass spectrometer, and TMT reporter ions were quantified from theMS3
scan (46). Peptides were identified and quantified using a Sequest-based
in-house software pipeline. The human UniProt database was searched,
and peptide spectral matches were filtered to a 1% false discovery rate
(FDR) using linear discriminant analysis in conjunction with the target-
decoy method (47). The resulting data set was further collapsed to a final
protein-level FDR of 1%. Protein assembly was guided by principles of
parsimony. Proteins were quantified by summing TMT reporter ion
counts across all matching peptide matches after filtering on the basis of
isolation specificity. Reverse and contaminant proteins were removed,
and protein quantitation values were exported for normalization and fur-
ther analysis inMicrosoft Excel software. Hierarchical centroid clustering
based on an uncentered Pearson correlation was performed using Cluster
software (v3.0; Stanford University) and visualized using Java TreeView
software (http://jtreeview.sourceforge.net).
Competition assays.MDCKcells were infectedwith equal numbers of
PFUof two viruses, and the progeny viruseswere subjected to plaque assay
under a 0.6% agarose overlay for 48 h. Individual plaque picks were am-
plified inMDCK cells, and 24 h later, the viral RNA in the supernatant was
extracted using the TRIzol reagent (Life Technologies), while the cells
were lysed in SDS-PAGE sample buffer. To identify the source of seg-
ment 8, cDNA was synthesized using avian myeloblastosis virus re-
verse transcriptase (Promega) and a primer complementary to the 3=
end of the PR8 NS segment vRNA (AGCAAAAGCAGGGTGAC) that
also efficiently primes reverse transcription from segment 8 vRNA of
all avian virus strains used in this study. RT-PCR was performed using
Taq DNA polymerase (Invitrogen) and primers specific for the NS1
open reading frame of A/green-winged teal/Ohio/175/1986 (H2N1)
(O175A) (forward primer, GCAACCGGTACCATGGATTCCAACAC
TGTGTC; reverse primer, GGTTGCACCGGTGTAACTTCTGACTC
AATTGTTC) and O265B (forward primer, GCAACCGGTACCATGG
ACTCCAACACGATAACC; reverse primer, GGTTGCACCGGTGTA
ACTTCTGACTCAACTCTTC). Alternatively, the NS1 content of cell
lysates was analyzed by SDS-PAGE and Western blotting, using the
differential reactivity of rabbit polyclonal antisera V29 (which detects
PR8 and O175A NS1) and A2 (which detects O175A and O265B NS1)
to score plaque picks.
Mouse infections. BALB/c mice were purchased from Harlan UK Ltd.
(Oxon, UK). All work was carried out under a UK Home Office license ac-
cording to theAnimals (ScientificProcedures)Act 1986. Five- to 6-week-old
female mice were anesthetized using isoflurane (Merial Animal Health
Ltd.) and infected intranasally with 500 PFU of virus in 40 l serum-free
D-MEM. The mice were weighed daily and assessed for visual signs of
clinical disease, including inactivity, ruffled fur, and labored breathing. At
days 2, 4, and 6 p.i., mice were euthanized by CO2 asphyxiation. The tip of
the left lung was harvested into preservative (RNAlater; Life Technolo-
gies) prior to RNA extraction, while the remainder of the left lung was
removed, homogenized in serum-free D-MEM, and clarified by centrifu-
gation. The titers of infectious virus in the left lung were determined by
plaque assay onMDCK cells. The lobes of the right lungwere fixed in 10%
(vol/vol) neutral buffered formalin, before being processed and then em-
bedded in paraffin. Five-micrometer-thick sections were cut and stained
with hematoxylin and eosin before being assessed (in a blind manner) by
a pathologist (P.M.B.), and lesions were scored. The scoring systemwas as
follows: 0, no lesions; 1, mild, focal inflammation and rare degeneration
and necrosis; 2, moderate, multifocal inflammation with frequent ne-
crotic cells; and 3,marked,multifocal inflammationwith commonnecro-
sis and occasional fibrin accumulation. For immunofluorescence imag-
ing, lung tissue was deparaffinized and stained for intracellular viral NP
using rabbit polyclonal antiserum (antiserum 2915). The lung tissue was
subsequently stained with an anti-rabbit IgG antibody conjugated with a
fluorescent dye (Alexa Fluor 594; Life Technologies), prior to immuno-
fluorescent imaging using a confocalmicroscope (model LSM710; Zeiss).
Mouse RT-qPCR array. Custom TaqMan array plates (Applied Bio-
systems) were designed to analyze 3 RNA samples per plate, with 32
unique assays being performed per sample. Individual RT-quantitative
PCR (qPCR) assays for cellular transcripts (see Table S1 in the supple-
mental material) were purchased fromApplied Biosystems and were used
according to the manufacturer’s recommendations. Total RNA was ex-
tracted from the tip of the left lung of 3 mice per cohort at day 4 p.i. using
an RNA extraction kit (QIAshredder; Qiagen) as instructed by the man-
ufacturer. cDNA was synthesized from 25 ng total RNA with random
hexamer primers using a high-capacity RNA-to-DNA reverse transcrip-
tion kit (Applied Biosystems) according to the manufacturer’s instruc-
tions. cDNA was loaded with TaqMan Universal Mastermix (Life Tech-
nologies) and run according to the manufacturer’s instructions in a 7500
qPCR thermocycler (Applied Biosystems). Cycle threshold (CT) values
were obtained using 7500 software (v2.0.6; Applied Biosystems) ac-
cording to the manufacturer’s instructions, and data were exported to
Microsoft Excel software for further analysis. Raw CT values were nor-
malized to GAPDH (glyceraldehyde-3-phosphate dehydrogenase) CT
values (dCT) and plotted as 20  dCT.
Bioinformatics.All segment 8 sequenceswere downloaded fromGen-
Bank via the Influenza Virus Resource (48) on 17 October 2014 (31,315
sequences). These data contained sequences isolated from avian (43%),
swine (10%), human (44%), and other (3%) hosts. Due to the large num-
ber of sequences, the sequences were aligned by nucleotides in groups
using the ClustalW tool in BioEdit software, manually adjusted for the
NS1 coding frame with the remaining nucleotides in the NEP coding
frame, and then aligned by amino acid sequence using the MUSCLE pro-
gram in MEGA software (v6.0). The major lineages of influenza A virus
segment 8 (avian virus A allele, human seasonal virus, classical swine
virus, H1N1 pdm2009 virus, avian virus B allele) were identified in neigh-
bor-joining trees; we split the data into 10 random subsamples of approx-
imately 3,100 sequences each tomake 10 trees, all the sequences belonging
to the avian virus lineages were extracted from the random subsamples
and combined, and the alignments were rechecked. Sequences with iden-
tical isolate names, mixed subtypes, unknown location, or year were ex-
cluded to make the avian virus A-allele (10,914 sequences in total, of
which 9,617 were avian virus sequences) and avian virus B-allele (2,725
sequences in total, of which 2,717 were avian virus sequences) data sets
(see Table S2 in the supplemental material for the distribution of se-
quences by all major lineages, hosts, geographic locations, and subtypes).
In order to determine the number of independent introductions
from birds to mammals in the avian virus A-allele and avian virus
B-allele data sets, we created phylogenetic trees using the neighbor-
joining method in MEGA software (v6.0) (with the Tamura-Nei
model, gamma-distributed rates among sites and heterogeneous pat-
terns among lineages) in the first instance. For the avian virus B-allele
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data set, there were only 8 non-avian virus sequences in total, and by
inspection, 2 pairs of them were the same or closely related in the tree,
leaving a total of 6 introductions (Table 2).
The avian virus A-allele data set was too large to make one tree for
manual inspection; therefore, we subsampled the avian virus sequences
(but not the non-avian virus sequences) to a maximum of 3 per year,
subtype, host species type, and geographic region in order to make a tree
of 4,886 sequences in total. In this tree, wemanually identified sublineages
where there weremajor introductions of an avian virus-derived segment 8
into mammals (old H7N7 equine virus, H7N7-H3N8 equine-canine vi-
ruses, Eurasian swine virus, H9N2 human and swine viruses, H7N9 vi-
ruses from human cases, H10N8 viruses from human cases, H3N2 canine
virus, HPAI H5N1 virus) and then marked the other non-avian virus
sequences in FigTree software (see Fig. S1 in the supplemental material).
For all of the 6 avian virus B-allele introductions, one representative
sequence from each highlighted avian virus A-allele sublineage, and all the
other avian virus A-allele non-avian virus sequences, a BLAST search for
the 100 closest other sequences (or 500 other sequences in a minority of
cases) was performed against the sequences in GenBank (using custom R
scripts). The returned sequences for each BLAST search were analyzed,
and the host, subtype, year, and geographic region properties for those
which were isolated between 3 and 0 years before the query sequence was
isolated (or 3 years before and after it was isolated if there were not suffi-
cient returns) were extracted and summarized to estimate the source (do-
mestic or wild birds) of the mammalian introductions. We also used an
alternativemeans to estimate the source of themammalian introductions:
a neighbor-joining tree from the returned sequences was constructed (per
query sequence), and a simple discrete trait model for host species (states
consisting of domestic-galliformes, domestic-anseriformes, wild-anseri-
formes, wild-other, and nonavian), assuming equal rates, was fitted using
the R package APE (49) to enable the inference of the avian host species
of the ancestor of the mammalian virus sequence (or sequences). Finally,
all the small trees generated from the BLAST searches were manually
inspected, and searches of the literature were performed to obtain infor-
mation about the query isolate. Results for nonindependently introduced
isolates were removed, and a final list of independent mammalian intro-
ductions from avian sources was compiled by manual curation (Tables 2
and 3; see also Table S3 in the supplemental material).
RESULTS
Avian virus A- and B-allele NS segment reassortants replicate
efficiently inmammalian cells.As a first test ofwhether introduc-
tion of an avian virus-derived A- or B-allele segment 8 into a
mammal-adapted virus introduced a fitness penalty in cultured
mammalian cells, a panel of segment 8 reassortant viruses was
generated on the background of PR8. TheNS segmentswere taken
from a variety of North American LPAI virus strains collected
between 1986 and 2005 (Table 1) and were introduced into PR8
using a well-established reverse genetics system (34). The NS1
proteins of these viruses within their respective A- or B-allele
group were at least 99% homologous and typically shared only
71% amino acid sequence homology between groups (see Fig. S2
in the supplemental material), consistent with previous reports
(23, 24). All viruses were readily rescued. To assess viral protein
expression during infection, MDCK cells were infected at anMOI
of 3, and cell lysates were taken at 8 h p.i. and subjected to SDS-
PAGE and Western blotting for viral NP, M1, M2, and NS1 pro-
teins. All viruses produced comparable amounts of NP, M1, and,
with some minor fluctuations, M2 (Fig. 1). NS1 from all viruses
was also readily detected, with anti-PR8 NS1 serum V29 reacting
with PR8 and the A-allele polypeptides and the B-allele serum A2
reacting with all avian virus NS1s. Avian virus NEPs could not be
reliably detected by Western blotting with the available antisera
(data not shown), but immunoprecipitation of radiolabeled cell
lysates with the same serum provided unambiguous evidence of
NEP expression by all viruses (Fig. 1). Thus, introduction of an
LPAI virus strain NS segment of either the A- or B-allele lineage
did not obviously attenuate viral protein expression in MDCK
cells.
To assess the replicative capabilities of the reassortant viruses
inmammalian cells,MDCKcells were infected at anMOIof 0.001,
and virus in the supernatant was titrated by plaque assay at 48 h
p.i. All viruses replicated to greater than 108 PFU/ml, and there
were no statistically significant differences (assessed by an un-
paired t test) between A- and B-allele reassortant virus titers (Fig.
2A). Additionally, the plaque phenotypes in MDCK cells were
indistinguishable between the viruses (data not shown). We next
investigated virus growth kinetics;MDCK cells were infected at an
MOI of 0.001 with either wild-type (WT) PR8 or consensus A-
and B-allele NS segment reassortants (O175A andO265B, respec-
tively), and virus in the supernatant was titrated across a time
course. All viruses replicated with similar growth kinetics, pro-
TABLE 2 Independent introductions of avian virus B-allele NS segments into mammalian hosts
Strain Host Transmission Notes (reference)
GenBank accession
no. (NS segment) Avian source
A/equine/Jilin/1/1989 (H3N8) Equine Epidemic Major equine influenza epidemic (25) M65020 Domestic
A/muskrat/Buryatiya/1944/2000
(H4N6)
Muskrat Single isolate Closely related to an H4N6 avian influenza
virus circulating in Russia at a similar time
point (70).
GU052363.1 Wild
A/swine/KU/16/2001 (H7N2) Swine Likely single isolate Isolated from 1 pig (of 532 tested) from a
slaughterhouse; apparent reassortment
between avian H7N2 and H5N3 viruses (71).
CY067690 Domestic
A/swine/Saskatchewan/18789/
02 (H1N1)
Swine Likely transmissible in
pigs
Isolated from a 1,200-sow pig farm where
influenza-like symptoms affected pigs of all
ages; fully avian virus (72)
AY619957 Wild
A/New York/107/2003 (H7N2) Human Single isolate Apparent individual infection of a 48-year-old
immunocompromised man from the
Caribbean with fever and flu-like symptoms;
no apparent transmission to family (73)
EU587374.2 Domestic
A/swine/Korea/C13/2008
(H5N2)
Swine Apparent transmission Serological evidence of transmission within
pigs (maybe asymptomatic?) (74)
FJ461601.1 Wild
Inﬂuenza A Virus Segment 8 and Host Adaptation
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ducing a peak viral titer of approximately 108 PFU/ml at 24 h p.i.
(Fig. 2B). To assess virus replication in continuous human cells,
A549 cells were infected at an MOI of 0.001, and virus in the
supernatant was assessed at 48 h p.i. All viruses replicated to sim-
ilar endpoint titers of approximately 107 PFU/ml (Fig. 2C).When
the kinetics of replication of consensus reassortant viruses were
examined in A549 cells, WT PR8 and O265B were essentially in-
distinguishable, while O175A replication slowed after 24 h to
reach an endpoint titer that was approximately 1 order of magni-
tude lower than that of WT PR8 and O265B (Fig. 2D). Similarly,
the whole panel of segment 8 reassortant viruses replicated to
viral titers similar to the titer of WT PR8 following multicycle
infection of human epithelial colorectal adenocarcinoma cells
(data not shown). To assess replication in primary human cells,
CD14 monocyte-derived macrophages (MDMs) were in-
fected at an MOI of 3, and virus in the supernatant was titrated
at 24 h p.i. All viruses replicated to similar titers of greater than
106 PFU/ml (Fig. 2E). Therefore, introduction of avian virus
NS segments of both the A- and B-allele lineages does not nec-
essarily attenuate PR8 virus replication in primary or continu-
ous human cell lines.
Since we had failed to observe any significant attenuation of
virus replication using the North American NS segment reas-
sortant LPAI viruses, we generated further reassortant viruses us-
ing NS genes that spanned a wider date and geographical range
and that either had been studied previously (18, 27) or were
deemed to be of particular interest, such as the A/equine/Jilin/1/
1989 (H3N8) (J89B) NS segment or the human isolate A/New
York/107/2003 (H7N8) (NY107B) (Table 1). Reassortant vi-
ruses were generated on the PR8 background as before, and
multicycle replication in MDCK cells was assessed. Again, all
viruses replicated to titers approaching 108 PFU/ml, with no
obvious difference between viruses with the A and B alleles
being detected (Fig. 2F).A/
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FIG 1 Protein synthesis by NS segment reassortant viruses in mammalian cell
culture. MDCK cells were infected at an MOI of 3, and cell lysates were pre-
pared at 8 h p.i. To detect viral NP, NS1, M1, and M2 polypeptides as well as
cellular tubulin, lysateswere subjected to SDS-PAGE and immunoblottedwith
the appropriate antisera. To detect NEP, cells were infected at an MOI of 10
and metabolically labeled with a 35S protein labeling mix between 6 h and 8 h
p.i. The lysates were then immunoprecipitated with anti-NEP antiserum, and
precipitates were analyzed by SDS-PAGE and autoradiography. Data are rep-
resentative of those from more than one independent experiment.
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FIG 2 A- and B-allele reassortant viruses replicate efficiently in mammalian cell culture. (A, B) MDCK cells were infected at an MOI of 0.001 with PR8-based
viruses, and the supernatants were titrated by plaque assay after 48 h (A) or at the plotted time points (B). Data in panel A are themean	 SD (n
 5), while panel
B presents the results of a single experiment. (C) A549 cells were infected with the indicated viruses at anMOI of 0.001, and endpoint titers were determined after
48 h. Data are the mean	 range (n
 2). (D) The replication kinetics of PR8 NS segment reassortants in A549 cells were determined as described in the legend
to panel B. Data are the mean	 SD (n
 3). (E) Primary human CD14MDM cells were infected with PR8-based viruses at an MOI of 3, and the titers in the
supernatant were determined after 24 h. Data are the mean 	 range (n 
 2). A duplicate sample of PR8-infected cells was taken immediately after the virus
adsorption period (postwash), and titers were determined to confirm that the virus in samples collected at later times reflected true virus replication and not
carryover of the virus inoculum. (F) Results of assays performed as described in the legends to panels A and B. Data represent the mean	 range (n
 2). (G)
MDCK-SIAT cells were infectedwithCal7-based viruses at anMOI of 0.01, and the supernatant was titrated at the plotted time points. Data are themean	 range
(n
 2). (H)MDCK cells were infected with Udorn72-based viruses as described in the legend to panel B. Data represent themean	 range (n
 2). Dotted lines
indicate the limit of detection.
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To test if these results were specific to the laboratory-adapted
PR8 backbone, we generated NS segment reassortant viruses on
the backgrounds of the human pandemic H1N1 strain Cal7 or
H3N2 strainUdorn72 and assessedmulticycle growth inmamma-
lian cells. MDCK-SIAT cells were infected with the Cal7 reas-
sortant viruses at anMOIof 0.01, and infectious progeny viruswas
titrated at the time points indicated below by plaque assay. The
WT Cal7 and the Cal7-PR8 reassortant viruses replicated with
similar kinetics, with peak titers being 106 PFU/ml at 72 h p.i. (Fig.
2G). In comparison, the segment 8 reassortant avian viruses dis-
played delayed growth kinetics and gave 10-fold lower peak ti-
ters at 72 h p.i. than WT Cal7. However, the replication kinetics
between the Cal7-based A- and B-allele reassortant viruses were
indistinguishable, providing no evidence for a B-allele-specific ef-
fect. All the Udorn72 viruses replicated in MDCK cells with sim-
ilar growth kinetics, barring minor differences at 24 h p.i., giving
peak titers of approximately 107 PFU/ml (Fig. 2H). Overall, there-
fore, introduction of either avian virus A- or B-allele NS segments
into human H1N1 and H3N2 strains does not generally attenuate
replication inmammalian cells in vitro. This suggests that the NS1
proteins and NEPs of avian viruses of both the A- and B-allele
lineages are able to carry out essential functions efficiently in
mammalian cells during infection.
AB-alleleNS1 protein is efficient at controlling themamma-
lian innate immune response in vitro. Since it has been suggested
that NS1 proteins belonging to the B-allele lineage cannot effi-
ciently suppress a mammalian host innate immune response (26–
29, 50), we investigated the ability of the consensus PR8 segment 8
reassortant viruses to circumvent and control the host cell type I
IFN response. First, human A549 cells were preconditioned for 24
h with various concentrations of human IFN- prior to infection
at anMOI of 0.01. The endpoint titers of these multicycle replica-
tion reactions were then determined by plaque assay, while cell
lysates were subjected to SDS-PAGE and Western blotting for
Mx-1, viral NP, and tubulin. All viruses displayed a similar dose-
response to exogenous IFN- treatment, being largely insensitive
to treatment with less than 10 U/ml but increasingly inhibited by
higher doses (Fig. 3A). The IC90 values were very similar between
PR8, O175A, and O265B (28.5 U/ml, 29.6 U/ml, and 33.5 U/ml,
respectively). Increased concentrations of IFN- pretreatment
correlated with increased levels of the interferon-sensitive Mx-1
protein and decreased levels of viral NP (Fig. 3B). Therefore, both
A- and B-allele NS segment reassortant viruses are as effective as a
mammal-adapted virus at replicating in the presence of prior in-
duction of the host innate immune response in mammalian cells.
Next, we investigated the levels of type I IFN secreted from A549
cells in response to virus infection. A549 cells were infected for 24
h at anMOI of 3, 0.3, or 0.03 withWT and reassortant PR8 viruses
or, as a positive control, with a PR8 NS1 mutant (R38K41A)
known to be defective in its control of type I IFN expression (51,
52). The supernatants were then treated with UV light to inacti-
vate virus, and the amount of type I IFN on HEK-Blue cells in
comparison to the amount on a standard curve generated with
known amounts of IFN- was estimated by bioassay (53). Cells
infected with the R38K41A virus at high or lowmultiplicities pro-
duced approximately 100 U/ml type I IFN (Fig. 3C). In contrast,
WT PR8, O175A, and O265B infection (at any MOI tested) failed
to induce levels of type I interferon significantly above the back-
ground level of the assay (approximately 6.75 U/ml IFN-). We
then assessed the full panel of PR8- and Udorn72-based reas-
sortant viruses at an MOI of 3, and in no case was type I IFN
detected in the supernatant of infected A549 cells at levels above
the background levels (Fig. 3D and E). Thus, LPAI virus A- and
B-allele NS1 proteins are able to effectively suppress type I IFN
expression during infection to a level below that estimated to be
inhibitory to virus replication, on the basis of dose-response
curves of human IFN- (Fig. 3A). Additionally, we tested various
A- and B-allele NS1 proteins for their ability to block the activa-
tion of the IFN- promoter following stimulation with poly(I·C)
and found that all avian virus NS1s tested were sufficient in block-
ing this activation (data not shown). These data suggest that B-al-
lele NS1 proteins are in fact able to successfully suppress the over-
all mammalian interferon response in vitro, contrary to previous
reports (26–29).
We next looked at cytokine and chemokine secretion from
infected primary humanmacrophages, sincemacrophages are im-
portantmediators of the host immune response to influenza virus
infection (54, 55). Human CD14 MDMs were infected at an
MOI of 1, and the supernatant was harvested after 24 h. Successful
infectionwas demonstrated byWestern blotting for viral NP (data
not shown). The levels of various secreted cytokines and chemo-
kines following infection with PR8, O175A, or O265B were then
quantified using an antibody capture array. Infection led to the
upregulation of several cytokines and chemokines relative to the
level of secretion in a mock-infected sample, with macrophage
inhibitory factor (MIF), tumor necrosis factor alpha (TNF-),
chemokine (C-C)motif ligand 3 (CCL3), chemokine (C-C)motif
ligand 5 (CCL5), C-X-Cmotif chemokine 10 (CXCL10), interleu-
kin 16 (IL-16), interleukin 1 receptor antagonist (IL-1ra), inter-
leukin 1 (IL-1), and C-X-C motif chemokine 12 (CXCL12) all
being upregulated at least 2-fold following infection with all three
viruses (Fig. 4A). The O175A and O265B reassortant viruses pro-
duced similar secretome profiles, and in both of these samples the
levels of proinflammatory mediators TNF-, CCL3, and CCL5
were lower than those resulting fromWT PR8 infection (Fig. 4A).
Thus, there is no evidence to suggest that there is an elevated
macrophage response to viruses with a B-allele NS segment in
humanmacrophages in vitro in comparison to that to viruses with
an A-allele counterpart.
To assess the global host cell response to infection with NS
segment reassortant viruses, we measured changes in host cell
proteins over a full time course of infection with each virus in
A549 cells using a new technology, multiplexed tandem mass tag
(TMT)-based mass spectrometry (45). This technology enables
FIG 3 A B-allele reassortant is not deficient in controlling the host IFN response in mammalian cell culture. (A, B) Ability of viruses to replicate despite
established antiviral conditions. A549 cells were pretreated with various concentrations of human recombinant IFN- for 24 h prior to infection with the
indicated PR8 viruses at an MOI of 0.01. (A) Virus in the supernatant was titrated by plaque assay at 24 to 48 h p.i. Data are the mean titers from 24-h and 48-h
multicycle infections. (B) Cell lysates were prepared at 48 h p.i., subjected to SDS-PAGE, and immunoblotted for cellular IFN-inducible Mx-1, viral NP, and
tubulin. (C to E) Induction of host cell type I IFN response during infection with reassortant viruses. (C)Human lung A549 cells were infected for 24 h at various
multiplicities, and active type I IFN in the supernatant was quantified using the HEK-Blue reporter cell line. (D, E) Results of assay performed as described in the
legend to panel C but at an MOI of 3.
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direct comparison of temporal infection with each virus within a
single experiment. Cells were infected at an MOI of 5, and cell
lysates were taken at 8 h, 16 h, and 24 h p.i. Immunofluorescent
analysis of NP expression confirmed amean infection rate of 95%
across all virus-infected samples and time points (data not
shown). A total of 6,862 unique proteins were quantified, and
these were clustered according to the fold change in expression
relative to that for the uninfected samples (Fig. 4B). The abun-
dance of only a minority of cellular proteins changed significantly
in response to infection, with themajority of these decreasing (see
Table S4 in the supplemental material). However, the IFN-induc-
ible factors Mx-1, interferon-induced protein with tetratricopep-
tide repeats 2 (IFIT2), 2=-5=-oligoadenylate synthetase-like pro-
tein (OASL), interferon-induced protein with tetratricopeptide
repeats 3 (IFIT3), interferon-induced protein with tetratricopep-
tide repeats 1 (IFIT1), and interferon-induced protein with heli-
FIG 4 Induction of host innate immune response during infection with reassortant viruses. (A) Human CD14MDMs were infected at an MOI of 1 for 24 h,
and the levels of various cytokines and chemokines in the supernatant were determined using an immunospot blot array. Values represent those from a heatmap
of the mean fold change in the level of expression with respect to the level in a mock-infected sample (Mock). sTREM-1, serum soluble triggering receptor
expressed onmyeloid cells-1; sICAM-1, soluble intercellular adhesionmolecule-1; CSF2 and CSF3, colony-stimulating factors 2 and 3, respectively. (B, C) A549
cells were infected at anMOI of 5, cell lysates were generated at the indicated times, and the polypeptide compositionwas determined by TMT-based quantitative
mass spectrometry. (B)Values represent those from a heatmap of themean fold changewith respect to the value formock-infected samples. The zoomed portion
shows a subcluster of heavily upregulated antiviral proteins. (C) The quantitative temporal expression of specific antiviral restriction factorsMx-1, IFIT2, OASL,
IFIT3, IFIT1, and IFIH1 is plotted.
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case C domain 1 (IFIH1) formed one example of a subcluster of
highly upregulated host factors in the PR8-infected samples (Fig.
4C). The genes for these proteins were also induced in O175A-
andO265B-infected cells, but generally to a lesser extent (Fig. 4C).
Thus, WT PR8 was actually a greater inducer of host antiviral
responses than either A- or B-allele NS segment reassortant avian
viruses, suggesting that neither the A- nor B-allele NS1 proteins
from avian viruses are deficient in controlling the mammalian
innate immune response.
Relative fitness of A- and B-allele segments. To assess more
subtle differences in replicative fitness between NS segment reas-
sortant viruses, we performed mixed infections and then esti-
mated the proportion of progeny virus that carried A- or B-allele
NS segments. Initially, we tested whether, over the course of mul-
tiple rounds of replication in mammalian cells, the A-allele NS
segment had a selective advantage in mammalian cells that would
let it outcompete the B-allele NS segment. MDCK cells were in-
fected with both O175A and O265B at an MOI of 0.001 each, and
at 48 h p.i., clonal populations of progeny virus were isolated by
plaque purification. Allele-specificRT-PCRswere then performed
to identify the source of segment 8. Control reactions showed that
a strong signal was obtained only with PCR mixtures containing
homologous viral RNA and primers (Fig. 5A, lanes 1 to 4 and 9 to
14), such that individual plaques picked from coinfections could
be unambiguously scored (see lanes 5 to 8 in Fig. 5A for examples).
When 25 plaques from the coinfection were scored by this
method, the B allele accounted for over 60% of the progeny
(Fig. 5B). The output virus population was further passaged twice
at an MOI of 0.001, and 25 plaques were assayed at each passage.
O265B maintained an advantage over O175A through these mul-
tiple rounds of replication, forming 72% of plaques by passage 3
(Fig. 5B). When either avian virus segment 8 was similarly com-
peted against the wild-type PR8 segment 8, PR8 heavily outcom-
peted both O175A (96% versus 4%) and O265B (88% versus
12%) by the end of the third passage (Fig. 5B). Thus, there was no
evidence of even a small replicative fitness penalty forO265B com-
pared to the fitness of O175A (if anything, the B allele appeared to
win), but both avian virus segments were less fit than the PR8
gene.
Previously, we suggested that differences in the terminal pack-
aging signal regions of segment 8 might restrict the incorporation
of the B allele into an A-allele background (56). To test this, we
performed high-multiplicity coinfections, such that the majority
of infected cells would be expected to contain segment 8s of both
backgrounds; the proportion of progeny virions containing an
individual NS gene would therefore reflect the facility with which
it was packaged into the PR8 virus background. MDCK cells were
infected at an MOI of 3 per virus, and at 16 h p.i., progeny virus
was collected and individual plaques were assayed as described
above. When O265B was competed against O175A in three inde-
pendent experiments, allele B-containing plaques outnumbered
O175A plaques by approximately 3:1 (Fig. 5C). RT-qPCR analysis
of intracellular segment 8 levels showed a 2.5:1 ratio in favor of the
B-allele segment (data not shown), suggesting that the packaging
efficiencies of O175A and O265B NS vRNA were similar. Simi-
larly, when either of the avian virus segment 8s was competed
FIG 5 Relative fitness of PR8 reassortant viruses. (A) Establishment of a strain-specific RT-PCR assay for A- and B-allele viruses. Viral RNA was extracted
following plaque purification of eitherO175A,O265B, or (as examples) 2 unidentified viruses obtained fromcoinfectionwith both and analyzed byRT-PCRwith
primers specific for the NS segment of either O175A orO265B. (B)MDCK cells were coinfected with the indicatedmixtures of viruses at anMOI of 0.001 (each),
and at 48 h p.i., the supernatantwas analyzed by plaque assay. Twenty-five plaqueswere scored for the proportion of progeny, and a further portion of the original
supernatant was passaged further at an MOI of 0.001. (C) MDCK cells were infected with each virus at an MOI of 3, and the proportion of each virus in the
supernatant was assessed after 16 h (values aremeans SEMs for avian virus with the A allele versus avian virus with the B allele [A v B]; n
 3). (D) Five BALB/c
mice were coinfected with 250 PFU each of O175A and O265B. At day 6 p.i., the left lung of each mouse was harvested, and the proportion of each virus in the
lung homogenate was determined by plaque purification of 12 plaques and RT-PCR.
Turnbull et al.
9274 jvi.asm.org October 2016 Volume 90 Number 20Journal of Virology
against the PR8 segment in high-multiplicity coinfections, B-allele
plaques were nearly equal in proportion with WT PR8 plaques
(52% versus 48%), while WT PR8 modestly outcompeted O175A
(69% versus 31%) (Fig. 5C). Therefore, contrary to our original
hypothesis, there was no evidence for selective packaging of an
A-allele segment into PR8 virions when both A and B segments
were present in an infected cell.
We next looked at coinfection in vivo. Five BALB/c mice were
intranasally infected with 250 PFU each of O175A and O265B. At
day 6 p.i., the left lung of each mouse was harvested. Twelve
plaques from each lung homogenate were assayed, and the pro-
portion of O175A and O265B in the lung was estimated. In one
sample, viruses bearing the O175A segment 8 predominated, but
in all other samples, O265B provided the majority or even all
isolates (Fig. 5D).On average,O265BoutcompetedO175Aby two
to one (66% versus 34%) in vivo. Thus, there is no obvious selec-
tion advantage for an avian virus A-allele NS segment over a B-al-
lele counterpart either in vitro or in vivo.
AB-allele reassortant virus ismore pathogenic than an avian
virus A-allele counterpart in vivo. We assessed the ability of the
consensus segment 8 reassortant viruses to replicate and cause
disease in vivo. Groups of 5 BALB/cmicewere challengedwith 500
PFU of WT PR8, O175A, or O265B or mock infected with me-
dium.Mock-infectedmicemaintained a healthy bodyweight over
6 days, whereas all infected mice lost weight from day 3 onwards
(Fig. 6A). By this criterion, WT PR8 was the most virulent strain,
causing the greatest weight loss, whereas both avian virus segment
8s apparently led to attenuated disease. Surprisingly, however,
O265B induced more weight loss than O175A. The mean weight
loss at day 4 p.i. was 16.9%, 3.1%, and 8.4% of the starting body
weight for PR8-, O175A-, and O265B-infected mice, respectively
(n
 10). By day 6 p.i., PR8, O175A, and O265B induced a mean
weight loss of 25.8%, 8.2%, and 19.3%, respectively (n
 5). The
weight loss in each group was significantly different from that in
all other groups fromday 3 p.i. onwards, with the exception of that
in O175A-infected mice at day 5 p.i., in which the weight loss was
not significantly different from that in mock-infected mice (un-
paired t test) (Fig. 6A). The same outcome of PR8 causing the
greatest weight loss and O175A causing the least was obtained in
independent replicate experiments, including one with a lower
inoculation dose of 100 PFU/animal, where infection with WT
PR8 and the O265B reassortant gave mean nadir weights of
82.0%	 1.0% (standard deviation [SD]) and 91.7%	 2.1% (SD)
of the initial body weight on day 7, respectively, before recovery,
while O175A-infected animals gained weight throughout the ex-
periment (data not shown). Thus, introduction of avian virus NS
segments into PR8 attenuated disease in vivo, but this attenuation
was the least with a B-allele segment.
To further assess replication characteristics in vivo, the lungs of
infected mice were harvested at days 2 and 6 postinfection and
homogenized, and virus titers were measured. At day 2 p.i., all
three viruses had replicated to titers of about 1  106 PFU/ml of
homogenate, and while the average WT PR8 titer was approxi-
mately 3-fold greater than the titers of both O175A and O265B,
the differences were not statistically significant (unpaired t test)
(Fig. 6B). At day 6, the titers of all three viruses had dropped, but
to significantly different extents, with WT PR8 giving the highest
titers and O175A giving the lowest (unpaired t test). Thus, the
source of segment 8 had relatively little effect on virus replication
at early times postinfection but significantly affected virus clear-
ance. As before, however, the avian virus-derived B allele was less
attenuating than the avian virus-derived A allele. When lung sec-
tions obtained on days 2, 4, and 6 p.i. were examined by immu-
nofluorescent staining for viral NP, in all cases, infected cells were
found the most frequently in airway epithelia but also in intersti-
tial tissue (Fig. 6C). In general, the number of positive cells corre-
lated with the titers of infectious virus, with PR8-infected cells
appearing to be more widespread than O265B- and O175A-in-
fected cells (data not shown), but overall, the source of segment 8
did not noticeably affect virus tropism.
To assess and compare the severity of the pathology caused
by each of the viruses, at day 6 p.i. the lungs of infected mice
were fixed, processed, sectioned, stained with hematoxylin and
eosin, and then examined to assess and score the histopatho-
logical changes present. All three viruses caused lesions consis-
tent with IAV infection, characterized by mild to marked,
subacute, multifocal, nonsuppurative, bronchointerstitial
pneumonia with necrosis and fibrin accumulation. Degenera-
tion and necrosis of the epithelial cells lining the airways, ac-
companied by peribronchiolar, peribronchial, and perivascu-
lar inflammation, were consistent features (Fig. 7A). The
inflammatory infiltrate was predominantly lymphocytic and
histiocytic with variable numbers of neutrophils. Scoring of the
severity and extent of the changes revealed no difference in the
pathology present in mice infected with PR8, O265B, or O175A
(Fig. 7B).
To examine the antiviral response in vivo following infection
with the reassortant viruses, we first quantified the expression of
an array of antiviral genes (selected to represent cytokines and
chemokines, interferons, and interferon-sensitive genes; see Table
S1 in the supplemental material) in the lungs of infected mice at
day 4 p.i. using RT-qPCR. The expression of most genes was sig-
nificantly upregulated in infected mice in comparison to that in
themock-infected controls (Fig. 7C). In general,WTPR8 induced
more antiviral gene expression than eitherNS segment reassortant
virus, while O265B tended to induce antiviral gene expression
more than O175A. However, the majority of the differences were
not statistically significant, with the only exceptions being Csf1
andCsf3, both of whichwere significantly upregulated byWTPR8
in comparison to their level of regulation in O175A-infected mice
(n
 3; P 0.05, unpaired t test). There were no instances of gene
expression being significantly different between O175A- and
O265B-infected lungs. To check for the possibility of biologically
significant posttranscriptional regulation, we next created pro-
teome profiles of infectedmouse lung (using pooled lung homog-
enates from groups of 5 mice) at day 4 p.i. for various cytokines
and chemokines using an antibody capture array. WT PR8 infec-
tion induced higher levels of proinflammatory cytokines, such as
TNF-, CXCL12, and interleukin 6 (IL-6), than infection with the
segment 8 reassortant viruses, while the profiles in O175A- and
O265B-infected mice were more similar to each other than to the
profile in PR8-infected mice (Fig. 7D). Thus, in vivo as well as in
vitro, WT PR8 was the strongest inducer of the host antiviral re-
sponse, but in this background, an avian virus B-allele segment 8
caused greater disease than an A-allele counterpart and allowed
prolonged virus persistence in the host.
TheB-alleleNSgeneof influenzaAvirus reassorts intomam-
mal-adapted viruses at similar rates as the A-allele NS gene.The
behavior of our reassortant viruses failed to provide evidence that
the B-allele NS segment is especially maladapted to a mammalian
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host. However, this hypothesis is founded on the presumption
that B-allele segment 8s are rarely found in viruses isolated from
mammals, a view dating back over 25 years, when there were far
fewer IAV sequences available. We therefore decided to revisit the
question of how often avian virus-derived segment 8 jumps into
mammalian hosts, using the much larger number of virus se-
quences now available.
All NS segment sequences in GenBank were downloaded and
grouped into A or B alleles (see Materials and Methods and Table
S2 in the supplemental material). These sequences were phyloge-
netically clustered to identify the major lineages of influenza A
virus segment 8 (Fig. 8), including several obvious large clades of
isolates from mammalian hosts that had likely acquired an NS
segment from an ancestral avian IAV strain (e.g., human seasonal/
classical swine/pdm2009 virus, Eurasian swine virus). To identify
other bird-to-mammal transmission events, the trees were exam-
ined for phylogenetically incongruent examples of mammalian
virus isolates within otherwise avian virus-derived branches (Fig.
8 and 9; see also Fig. S1 and Table S3 in the supplemental mate-
rial). In some instances, these apparently represented single trans-
FIG 6 Pathogenicity of PR8 reassortant viruses in BALB/cmice. (A) Five BALB/cmice per groupwere nasally inoculated with 500 PFU of virus ormock infected
with medium, and their weight was measured every 24 h. Data represent the mean	 SD. Asterisks indicate statistical significance at day 6 postinfection, when
all animals were euthanized. (B) The left lung of eachmouse was harvested at either day 2 or day 6 p.i., and virus in the homogenate was titrated by plaque assay.
(C) Intracellular NP staining in infected mouse lung. Lung sections from mice at day 2 p.i. were stained for viral NP (red) and DNA (blue) and imaged using
confocal and differential interference contrast (DIC) microscopy. P values were determined by unpaired t tests. *, P 0.05; **, P 0.01; ***, P 0.005.
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mission events (when the limitations of sample bias are accepted),
whereas others clearly reflected the successful introduction of an
avian virus segment into amammalian virus population. Since we
wanted to estimate the numbers of independent introductions of
an avian virus A- or B-allele NS segment intomammalian viruses,
the latter class was still treated as one event. This approach iden-
tified 6 occasions in which a B-allele NS segment had demon-
strably transferred to amammalian host (Fig. 9; Table 2) and 32
occasions for A-allele NS segments (Table 3; see also Fig. S1 in
the supplemental material). Thus, A-allele jumps from Aves to
Mammalia hosts outnumber B-allele jumps by over 5 to 1. How-
ever, A- and B-allele segments may not be equally distributed
among the source population, as the total number of avian virus
A-allele sequences available in GenBank outnumbers the number
of B-allele sequences available by approximately 3.5 to 1 (Table 4;
see also Table S2 in the supplemental material). Using Fisher tests,
we found that the number of mammalian introductions per avian
virus isolate was not significantly different between the A and B
alleles (A allele, 32 from 9,617; B allele, 6 from 2,717; P
 0.436).
We further considered if there might be a difference in the de-
tected number of introductions depending upon whether the
avian source was wild or domestic birds, since the contact rate
between the often sampled domestic mammals (e.g., humans and
swine) and domestic birds could be very different from that for
wild birds. Indeed, a larger proportion of the avian virus B-allele
gene sequences than avian virusA-allele gene sequenceswere sam-
pled fromwild birds and fromNorth America (Fig. 10). However,
there was also no significant difference between A and B alleles
FIG 7 Host responses to A- and B-allele segment 8 reassortant viruses. (A) At day 6 p.i., the right lung lobes of inoculated mice were collected, fixed, processed,
and stained with hematoxylin and eosin. Mock-infected mice showed no significant changes, whereas infected mice showed degeneration and necrosis of
epithelial cells lining the airways with peribronchiolar and perivascular inflammation and interstitial inflammation sometimes accompanied by necrosis and
fibrin accumulation. The inflammatory infiltrate was predominately lymphocytes andmacrophages with variable numbers of neutrophils. Bars, 50m. (B) The
severity of the pathology in the lung was assessed in a blindmanner, and an overall pathology score out of 3 was assigned. (C) RNAwas extracted from the lungs
of infected mice at day 4 p.i., and the levels of various cytokines, chemokines, and antiviral gene expression were quantified using RT-qPCR. Data are plotted as
the mean (20 dCT)	 SD. The values for all infected samples were significantly different from the value for the mock-infected sample, unless the bar is labeled
with NS, which indicates no significant difference by the unpaired t test. *, P 0.05; **, P 0.01. (D) The levels of various cytokines and chemokines in pooled
lung homogenates from groups of 5 mice culled at day 4 p.i. were determined using an immunoblot spot array. Values are represented by those from a heat map
of the fold change with respect to the level of expression for the mock-infected samples.
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considering likely domestic bird-to-mammal (P
 0.756) or wild
bird-to-mammal (P
 0.578) introductions (Table 4). Thus, over-
all, the currently available surveillance/sequencing data do not
support the hypothesis that the B-allele NS segment is specifically
restricted to mammalian hosts but instead suggest that the intro-
duction of any avian virus segment 8 into mammals is a relatively
rare event.
DISCUSSION
To date, there has been conflicting evidence regarding the fitness
of IAV strains containing the B allele of NS segment 8 inmamma-
lian hosts, from early evidence for restriction in mammals
through to more recent studies that have begun to question this
(18, 26–30, 57). Here, we found nomajor fitness penalty incurred
in vitro or in vivo byH1N1 andH3N2mammal-adapted influenza
viruses forcibly reassorted with B-allele NS segments. We tested
three mammal-adapted backbone viruses and a panel of A- and
B-allele NS segments from a variety of isolates, predominantly
LPAI virus strains from North America (Table 1); all viruses rep-
licated to high peak titers in a variety of mammalian cell lines and
achieved normal viral protein expression (Fig. 1 and 2). NEP is
essential for virus replication (58), while deletion of NS1 severely
attenuates virus replication in cells (59). Thus, despite their diver-
gent avian virus origin, the B-allele NS1 proteins and NEPs are
both able to effectively carry out essential support functions in
mammalian cells in vitro. Indeed, in competition assays in vitro
and in vivo, the B-allele reassortant consistently outperformed its
avian virus A-allele counterpart (Fig. 5).
There is evidence, largely based on transfection-based reporter
assays examining the function of individual cellular promoters,
that B-allele NS1 proteins are less effective than their A-allele
counterparts at suppressing the activation of specific innate im-
munity pathways inmammalian cells (26–29, 50). Consistentwith
these data, we also found significant differences in the ability of
certain avian virus NS1s to antagonize RNA polymerase II-medi-
ated gene expression from transfected plasmids with simian virus
40 or the interferon-sensitive response element but not the IFN-
promoters (data not shown). However, in the context of virus
infection, both A-allele and B-allele H1N1 and H3N2 reassortant
viruses controlled the secretion of active type I IFN from infected
human lung cells to below an inhibitory level (Fig. 3C to E). These
observations are complemented by those from a previous report
showing that avian virus NS1 proteins from both the A- and B-al-
lele lineages were able to antagonize type I IFN induction in hu-
man cells in infection-based reporter studies (60). Additionally,
O175A and O265B displayed no obvious hypersensitivity to
IFN- pretreatment in human lung cells (Fig. 3A) and did not
stimulate a large cytokine/chemokine response in primary human
macrophages (Fig. 4A). In fact, both avian virus segment 8 reas-
sortants induced less of an antiviral response than wild-type PR8
virus in vitro in human lung cells (Fig. 4B and C) and in vivo in
mouse lungs (Fig. 7C and D). Thus, both A- and B-allele NS1
proteins from LPAI virus strains can effectively control the overall
mammalian innate immune response and circumvent an induced
antiviral state, even if, perhaps, the suite of mechanisms deployed
shows some differences.
We also considered whether penetration of the B-allele seg-
ment into mammalian strains of virus might be restricted at the
level of reassortment. IAV is known to package each segment spe-
cifically, with RNA packaging signals directing the process (56,
61). The packaging signals for segment 8 partially overlap variable
regions between the alleles, and we previously hypothesized that
this might hinder free reassortment of the avian virus B-allele
segment into an otherwise mammal-adapted virus background
(56, 62). However, the outcome of high-multiplicity coinfections
with the A- and B-allele viruses, in which every cell would be
expected to contain both segment 8s, which would then compete
for incorporation into the A-allele PR8 background, did not sup-
port the hypothesis, with the B allele outperforming the avian
virus A allele and drawing against the PR8 segment (Fig. 5C). This
outcome is consistent with that in other work indicating a surpris-
ing amount of plasticity in the segment 8 packaging signal (63).
Overall, the data therefore do not suggest that a B-allele NS vRNA
segment is less likely to be introduced into an IAV strain circulat-
ing in mammalian hosts by genetic reassortment in nature.
Having failed to find any convincing evidence for a replicative
penalty for the B-allele NS segment in vitro or in vivo, we began to
question the validity of the long-held view that the B allele is re-
stricted in mammals. There is evidence to suggest that the B-allele
NS segment of IAV attenuates a human IAV strain in vivo. Treanor
FIG 8 Major lineages of influenza A virus segment 8. A phylogenetic tree of a
subsample of all influenza A virus segment 8 sequences is shown, with the
major lineages being highlighted in color.
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et al. made human H3N2 NS reassortant viruses and noted an
attenuation in virus replication in the nasopharynx of squirrel
monkeys and a reduced shedding duration of a B-allele reas-
sortant virus in comparison to that for an A-allele counterpart
(18).However, the peak titer of the B-allele reassortant virus in the
trachea was not significantly reduced, suggesting that the virus
could replicate effectively in this part of the respiratory tract.Here,
we challenged BALB/c mice with PR8-based NS reassortant vi-
ruses and found that PR8, O175A, and O265B were all able to
cause clinical disease and replicate in vivo. Wild-type PR8 caused
the most severe disease in terms of weight loss (Fig. 6A), and this
could be due to a greater induction of cytokines, chemokines, and
interferon-sensitive genes in the lungs of infected mice (Fig. 7C
andD) or due to prolonged viral persistence in the lung, as judged
FIG 9 Mammalian virus B-allele segment 8 sequences. A phylogenetic tree of all avian virus B-allele lineage segment 8 sequences is shown, and the non-avian
virus sequences are highlighted.
TABLE 4 Expected number of avian B-allele introductions
Data
A allele B allele Fisher testa
No. of avian
virus strains
No. of independent
introductions
Introduction
rate
No. of avian
virus strains
No. of independent
introductions
Introduction
rate P value
Expected no. of
B-allele
introductionsb
All avian viruses 9,617 32 0.0033 2,717 6 0.0022 0.436 9.04 (4–15)
Transmissible viruses 9,617 19 0.0020 2,717 3 0.0011 0.446 5.37 (0–10)
Single isolates or viruses with poor
transmission
9,617 13 0.0014 2,717 3 0.0011 1.000 3.67 (0–8)
Viruses from domestic birds only 4,391 18 0.0041 648 3 0.0046 0.756 2.66 (0–6)
Viruses from wild birds only 5,168 12 0.0023 2,053 3 0.0015 0.578 4.77 (1–9)
a Calculated using data from A alleles, assuming a binomial distribution.
b Data in parentheses represent the range of the number of episodes that would still be statistically nonsignificant (P 0.1).
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by the viral titers at day 6 p.i. (Fig. 6B). It is not surprising that
wild-type PR8 caused the greatest disease, since this strain is al-
ready mouse adapted (64) (our PR8 clone has a 50%mouse lethal
dose [MLD50] of 100 PFU), and it is known that the NS1 and
NEP genes incur adaptive mutations following passaging in mice
(17). Nevertheless, both avian virus NS reassortants caused overt
disease, including indistinguishable levels of classical IAV-in-
duced lung histopathology. O265B induced more severe weight
loss thanO175A; however, the cytokine, chemokine, and interfer-
on-sensitive gene profiles in the infected mouse lung were not
significantly different between the two. PR8, O175A, and O265B
had similar peak viral titers at day 2 p.i., and the rate of clearance
was O175AO265B PR8, which was inversely correlated with
the severity of weight loss (Fig. 6B). Thus, in this mammalian
infection model, a B-allele NS segment is compatible with high
levels of virus replication and pathogenicity. Our study is not
alone in finding that a B-allele segment is compatible with viru-
lence in mice; a recent study found that insertion of a B-allele NS
segment into a PR8 variant with a markedly higher MLD50 of
105 PFU did not further attenuate the virus (65), while others
found that insertion of a B-allele NS segment into a previously
avirulent laboratory-adapted HPAI virus strain actually caused a
dramatic increase in pathogenicity (30). Thus, overall, B-allele-
containing viruses seem to be entirely capable of supporting sub-
stantial levels of virus replication and disease in laboratory animal
models.
Twenty years ago, the other main strand of evidence for host
restriction of B-allele NS genes was the paucity of mammal-de-
rived isolates (23, 24, 66). However, the number of sequenced IAV
isolates has since risen exponentially, and following the first report
of a mammalian (equine) B-allele-containing virus (25), a num-
ber of other instances of B-allele-containing virus from swine and
other species, including humans, have been noted (Table 2). It was
therefore important to reappraise the question of whether the in-
troduction of avian virus-derived NS segments into mammalian
hosts is truly biased against one allele or another. We identified
12,000 unique avian virus-derivedNS sequences inGenBank, of
which over three-quarters were A-allele segments. A parallel anal-
ysis of mammal virus-derived NS sequences for phylogenetically
incongruent sequences that represented introduction of an avian
virus gene into a mammalian host, as well as consideration of
well-established histories of IAV evolution (most notably, the
1918 avian virus NS segment, which founded the widespread clas-
sical swine, human H1N1, H2N2, H3N2, and pdm2009 virus lin-
eages from a single event), identified 32 separate instances of an
avian virus A allele and 6 of an avian virus B allele jumping into
mammals. This gives rates of 32/9,617 and 6/2,717, respectively,
or 0.0033 and 0.0022, respectively, for mammalian incursions per
unique avian virus isolate (Table 4). These estimates are poten-
tially affected by biases inherent to the data, most especially, sam-
pling bias. The B allele might truly be less prevalent in the avian
population, or it might preferentially infect bird species that are
FIG10 Distribution of avian virus segment 8 sequences. The host distribution and location of isolation are represented for all avian virus A- andB-allele segment
8 sequences.
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less frequently sampled (Fig. 10). For example, Adams et al. re-
ported that a B-allele reassortant was less competent than an A-al-
lele equivalent at replicating in chicken and turkey cells but was
more fit in duck cells (67). However, surveillance data show that
B-allele influenza viruses can infect poultry (Fig. 10) and have the
ability to persist (68) and to be highly pathogenic (69). Con-
versely, the mammalian isolates are undoubtedly biased in the
species that are sampled. We also accept that the boundary of an
independent introduction can be defined in different ways. For
instance, while forward transmission of the original avian virus-
derived equine H3N8 virus to dogs clearly does not count as two
independent introductions (going frombird tomammal tomam-
mal), how does one define the repeated zoonotic infection of a
widespread avian virus, such as H5N1, into humans? We chose to
define this as two major introduction events, the original 1997
event and the subsequent reintroduction from domestic poultry
in 2003, since the multiple human infections were monophyletic
in each case. Nevertheless, taken on face value, our analysis of the
currently available sequences does not support the hypothesis of
the B allele being specifically restricted to avian hosts. Instead, it
seems that the transfer of any avian virus segment 8 tomammals is
a relatively rare event.
Successful cross-species transmission does not necessarily
equate with establishment in the new host. Further inspection of
the Aves-to-Mammalia transmission events suggests a divide into
isolated events with little or no documented onward transmission
in the mammalian host and those where the virus containing the
avian virus segment 8 has persisted, at least for a period. The
available information suggests that 3 of 6 B-allele viruses were
transmitted between mammals, most notably, the 1989 H3N8
outbreak in horses (Table 2) (25). For the A-allele viruses, perhaps
19 out of 32 seem to have been transmissible, with half a dozen or
more events leading to the long-term establishment of the virus in
a new host. Statistically, these data do not support the hypothesis
that the transmissibility of IAV with allele A or B NS segments is
different (Table 4). However, the number of observed introduc-
tions is small, and there may be confounding effects from other
segments. Further work would be necessary to test the possibility
that transmission between mammalian hosts is attenuated due to
the B-allele NS segment. Overall, we conclude that it is misleading
to simply consider the B allele of the NS segment to be particularly
restricted to avian host species, a factor to be borne in mind when
assessing the risk of the zoonotic/epizootic potential of avian in-
fluenza strains (31).
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